Amneet Hans, MD
Gastroenterology · White Plains, NYNPI 1255794475
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,238 of the $7,013 with a category attached, or 88.9%. 21 manufacturers reported payments, led by AbbVie at 35.0% of the total. Reporting peaked in 2024 at $2,449 and has fallen 79.2% since, to $509 in 2025.
Across 173 payments — averaging $40.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$1K
- Takeda Pharmaceuticals U.S.A., Inc.$814
- Janssen Scientific Affairs, LLC$668
- Lilly USA, LLC$218
- Medtronic$168
- plus $1K from 15 others
What the payments were for
- Consulting fees$6609%
- Food & beverage$6,23889%
- Education$1152%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 58 | $2,453 |
| Johnson & Johnson | 11 | $1,329 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $814 |
| Janssen Scientific Affairs, LLC | 8 | $668 |
| Lilly USA, LLC | 10 | $218 |
| Medtronic | 2 | $168 |
| Boston Scientific | 1 | $168 |
| Organon | 15 | $149 |
| Bristol Myers Squibb | 10 | $135 |
| Intercept Pharmaceuticals, Inc. | 1 | $129 |
| Gilead | 1 | $125 |
| Aimmune Therapeutics, Inc. | 7 | $113 |
| Pfizer | 5 | $110 |
| E.r. Squibb & Sons, L.L.C. | 1 | $109 |
| Curonix LLC | 1 | $91 |
| Merck | 5 | $78 |
| Boehringer Ingelheim | 3 | $59 |
| Braintree Laboratories, Inc. | 2 | $33 |
| Ferring Pharmaceuticals Inc. | 1 | $29 |
| AstraZeneca | 1 | $19 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,013 in reported general payments places this provider in the 70th percentile of 1,682 gastroenterology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 13 | $3,002 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in White Plains
- David Carr LockeNew York$2M
- Arthur KornbluthNew York$1.9M
- Maya SrivastavaWilliamsville$1.8M
- Melissa PalmerPlainview$1M
- Sonal KumarNew York$1M
- David PoppersNew York$939K
- Ellen ScherlNew York$857K
- Bruce SandsNew York$810K
- Jean Frederick ColombelNew York$786K
- Seth GrossNew York$624K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.